After 10 years of following and a few rebrands (Mattoe/Gripper)...

After 10 years of following and a few rebrands (Mattoe/Gripper) you should be aware Serum Institute have been ordering and trialling various amounts of Anteobind since July 2020.

They have also released several published papers in conjunction with the UK MHRA the past year, utilising Anteobind with great success. I would call that validation and validation coming from the worlds largest vaccine manufacturer and UK gov health regulation arm.

Looks like they see the Anteobind as the blue chiip product for bio conjugation and so they should because it is. Judging by the amount of published research papers being released several other institutes and companies appear to be on the same path but will save them for another day.

Current market cap around $70m looks pretty good buying with both sides of the business making the right inroads to supply some very large and well known global companies. With an identified $1B opportunity in Anteo X sales, the very real potential to overtake EDC/NHS chemistry giving a potential of $700m in Anteobind sales and then the blue sky opportunities with in house anode now being manufactured at scale, hydrogen catalysts etc, etc.

GLTA